This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2019.
Company Filing History:
1 out of 834,350 Years Active: 2019
Title: Biljana Jankovic: Innovator in Pharmaceutical Chemistry
Introduction
Biljana Jankovic is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel hydrates of dolutegravir sodium. Her work is crucial in the fight against retroviral infections, including HIV-1.
Latest Patents
Biljana Jankovic holds 1 patent for her invention titled "Hydrates of dolutegravir sodium." This invention relates to novel hydrates of dolutegravir sodium and processes for their preparation. It also introduces a new crystalline form of dolutegravir sodium, which serves as a useful intermediate for creating one of the novel hydrates. Furthermore, her invention encompasses the use of these hydrates in producing pharmaceutical compositions, as well as oral dosage forms that include these compositions. The patent highlights the application of these pharmaceutical compositions in treating retroviral infections.
Career Highlights
Throughout her career, Biljana has worked with prominent companies, including Sandoz AG. Her expertise in pharmaceutical chemistry has allowed her to make impactful advancements in drug formulation and development.
Collaborations
Biljana has collaborated with talented individuals such as Andrea Thaler and Andrija Lebar. These partnerships have contributed to her innovative work in the pharmaceutical field.
Conclusion
Biljana Jankovic is a pioneering inventor whose work in pharmaceutical chemistry has the potential to improve treatment options for retroviral infections. Her contributions to the field are invaluable and continue to inspire future innovations.